- Conditions
- Adnexal Diseases, Advanced Solid Tumors, Biliary Tract Diseases, +53 more
- Locations
-
- UAB O'Neal Comprehensive Cancer Center - The Kirklin Clinic of UAB Hospital Birmingham, Alabama, United States
- City of Hope - Duarte Cancer Center Duarte, California, United States
- Florida Cancer Specialists & Research Institute - Fort Myers Cancer Center - Gladiolus Fort Myers, Florida, United States
- Dana-Farber Cancer Institute - Oncology Department Boston, Massachusetts, United States
Clinical trial condition
HER2 Mutation
Explore clinical trials studying HER2 Mutation. Study availability and eligibility vary by location and protocol.
8 public trials
2 recruiting studies
HER2 Mutation trial results
- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation
- Locations
-
- Banner MD Anderson Cancer Center at Banner Gateway Medical Center Gilbert, Arizona, United States
- City of Hope - Duarte Cancer Center Duarte, California, United States
- Emory Winship Cancer Institute Atlanta, Georgia, United States
- The Center for Cancer and Blood Disorders Bethesda, Maryland, United States
Not Yet Recruiting
A Phase II Study of Zongertinib Plus Fulvestrant in Participants With HR-positive/HER2-negative Advanced Breast Cancer Harboring HER2 Mutations.
NCT07619066
- Conditions
- Advanced Breast Cancer, HER2 Mutation, Hormone Receptor Positive / HER2-negative Breast Cancer
- Locations
-
Not specified
NCT06378658
- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, +1 more
- Locations
-
- Parexel Baltimore - Early Phase Clinical Unit Baltimore, Maryland, United States
NCT06329895
- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, +1 more
- Locations
-
- PAREXEL International Early Phase Clinical Unit (London) Harrow, United Kingdom
NCT06360211
- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, +1 more
- Locations
-
- Parexel Baltimore - Early Phase Clinical Unit Baltimore, Maryland, United States
Completed
A Study to Learn How BAY2927088 is Taken up and Handled by the Body in Healthy Male Participants
NCT06221475
- Conditions
- Advanced Non-Small Cell Lung Cancer, EGFR Mutation, HER2 Mutation, +1 more
- Locations
-
- ICON plc Groningen, Netherlands
NCT06348888
- Conditions
- Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +11 more
- Locations
-
- Parexel Baltimore - Early Phase Clinical Unit Baltimore, Maryland, United States